• Cytokinetics EPS for the quarter ending December 31, 2024 was $-1.26, a 8.7% decline year-over-year.
• Cytokinetics 2024 annual EPS was $-5.26, a 3.49% decline from 2023.
• Cytokinetics 2023 annual EPS was $-5.45, a 25.87% increase from 2022.
• Cytokinetics 2022 annual EPS was $-4.33, a 54.64% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.